Alignment among public formularies in Canada, part 1. General overview.: H82-29/1-2017E-PDF
"This first report in the series provides insight into the degree of alignment among the formularies. Based on 2015 data, this analysis compares the overall drug listings and unpacks specific market segments including single- and multi-source drugs, high-cost drugs, and a specified list of essential medicines."--Executive summary, p. ii.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.844013&sl=0
| Department/Agency | Canada. Patented Medicine Prices Review Board. |
|---|---|
| Title | Alignment among public formularies in Canada, part 1. General overview. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Concordance des listes de médicaments des régimes publics au Canada, partie 1 : Aperçu général. Cover title. Includes bibliographical references. |
| Publishing information | Ottawa : Patented Medicine Prices Review Board, 2017. |
| Description | iii, 31 p. : figs. |
| ISBN | 978-0-660-09799-2 |
| Catalogue number |
|
| Subject terms | Drugs Drug insurance |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: